Trademark Details For GLYFEX (Serial Number 97640597)

  •  Home
  •  Print
GLYFEX
1
3
2
0
Basic Information
Serial Number  United States - USPTO 97640597
Registration Number -
Mark
GLYFEX
Filing Date Oct-20-2022
Status
Pending  
SECOND EXTEN.. (731)
SECOND EXTENSION - GRANTED
Attorney Name
TTAB
0


  • TEVA PHARMACEUTICALS USA


005Pharmaceuticals

U.S Class(es): 005, 006, 018, 044, 046, 051, 052

Class Status: Active





Correspondences

NameLaurence Rickles TEVA PHARMACEUTICALS USA, INC.
Address400 INTERPACE PARKWAY BUILDING A PARSIPPANY, NJ 07054 United States

Prosecution History

USPTO 
DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Oct-24-2022NEW APPLICATION ENTERED   NWAPI
Oct-25-2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED   NWOSI
Aug-01-2023ASSIGNED TO EXAMINER   DOCKD
Aug-08-2023APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAP
Aug-23-2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED   NONPE
Sep-12-2023PUBLISHED FOR OPPOSITION   PUBOA
Sep-12-2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED   NPUBE
Nov-07-2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT   NOAME
Apr-24-2024SOU TEAS EXTENSION RECEIVED   EEXTI
Apr-24-2024SOU EXTENSION 1 FILED   EXT1S
Apr-24-2024SOU EXTENSION 1 GRANTED   EX1GS
Apr-25-2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED   EXRAE
Oct-29-2024SOU TEAS EXTENSION RECEIVED   EEXTI
Oct-29-2024SOU EXTENSION 2 FILED   EXT2S
Oct-29-2024SOU EXTENSION 2 GRANTED   EX2GS
Oct-29-2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED   EXRAE